Protara Therapeutics Inc. (TARA)
NASDAQ: TARA
· Real-Time Price · USD
4.08
0.50 (13.97%)
At close: Sep 24, 2025, 3:59 PM
4.43
8.58%
Pre-market: Sep 25, 2025, 08:09 AM EDT
13.97% (1D)
| Bid | 3.76 |
| Market Cap | 157.41M |
| Revenue (ttm) | 332K |
| Net Income (ttm) | -50.86M |
| EPS (ttm) | -1.56 |
| PE Ratio (ttm) | -2.62 |
| Forward PE | -2.14 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 4.15 |
| Volume | 1,414,726 |
| Avg. Volume (20D) | 334,963 |
| Open | 3.68 |
| Previous Close | 3.58 |
| Day's Range | 3.63 - 4.22 |
| 52-Week Range | 1.59 - 10.48 |
| Beta | 1.51 |
| Ex-Dividend Date | n/a |
About TARA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TARA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TARA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-18.52%
Protara Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
5 months ago
+6.6%
Protara Therapeutics shares are trading higher after the company announced it will review the interim data from its Phase 2 ADVANCED-2 trial.
